EFI
ESLAW icon

EHP Funds Inc’s Estrella Immunopharma Warrant ESLAW Stock Holding History

EHP Funds Inc’s Portfolio ESLAW Stock Details ESLAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-172,315
Closed -$41.4K – 212
2023
Q3 		$41.4K Hold
172,315
– – 0.02% 158
2023
Q2 		$9.03K Hold
172,315
– – ﹤0.01% 264
2023
Q1 		$17K Hold
172,315
– – ﹤0.01% 267
2022
Q4 		$9K Sell
172,315
-23,095
-12% -$1.93K ﹤0.01% 296
2022
Q3 		$13K Buy
195,410
+20,210
+12% +$3.42K ﹤0.01% 378
2022
Q2 		$44K Buy
175,200
+40,900
+30% +$9.08K 0.01% 344
2022
Q1 		$30K Buy
+134,300
New +$36.9K 0.01% 321

Other funds holding ESLAW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

EHP Funds Inc's ESLAW Position: Q4 2023 in Review

EHP Funds Inc sold out of Estrella Immunopharma Warrant (ESLAW) in Q4 2023, closing a stake of 172,315 shares — an estimated $41.4K sold.

EHP Funds Inc first reported a position in ESLAW in Q1 2022 and held it in 7 quarters. The position peaked at $44K in Q2 2022. 13 funds tracked by Wall St. Rank hold ESLAW as of Q4 2023.

  • EHP Funds Inc reported no remaining Estrella Immunopharma Warrant position as of Q4 2023 after selling out during the quarter.
  • EHP Funds Inc sold 172,315 Estrella Immunopharma Warrant shares in Q4 2023, an estimated $41.4K.
  • EHP Funds Inc first reported a position in Estrella Immunopharma Warrant in Q1 2022 and held it in 7 quarters.
  • EHP Funds Inc's Estrella Immunopharma Warrant position peaked at $44K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q4 2023.

Based on EHP Funds Inc's 13F filing for Q4 2023, filed 14 Feb 2024.